Correlation Between BRIM Biotechnology and Materials Analysis

Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and Materials Analysis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and Materials Analysis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BRIM Biotechnology and Materials Analysis Technology, you can compare the effects of market volatilities on BRIM Biotechnology and Materials Analysis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of Materials Analysis. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and Materials Analysis.

Diversification Opportunities for BRIM Biotechnology and Materials Analysis

0.69

Correlation Coefficient

BRIM Biotechnology  Materials Analysis

Poor diversification

The 3 months correlation between BRIM and Materials is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and Materials Analysis Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Materials Analysis and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with Materials Analysis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Materials Analysis has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and Materials Analysis go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and Materials Analysis

Assuming the 90 days trading horizon BRIM Biotechnology is expected to under-perform the Materials Analysis. In addition to that, BRIM Biotechnology is 1.17 times more volatile than Materials Analysis Technology. It trades about -0.19 of its total potential returns per unit of risk. Materials Analysis Technology is currently generating about -0.1 per unit of volatility. If you would invest  27,300  in Materials Analysis Technology on September 17, 2024 and sell it today you would lose (2,600) from holding Materials Analysis Technology or give up 9.52% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

BRIM Biotechnology  vs.  Materials Analysis Technology

BRIM Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Materials Analysis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Materials Analysis Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with BRIM Biotechnology and Materials Analysis

The main advantage of trading using opposite BRIM Biotechnology and Materials Analysis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, Materials Analysis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Materials Analysis will offset losses from the drop in Materials Analysis' long position.

The idea behind BRIM Biotechnology and Materials Analysis Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.